Dextromethorphan Hydrobromide/Quinidine Sulfate (Beijing Kangchuanglian Biopharma)

氢溴酸右美沙芬/硫酸奎尼丁口崩片（北京抗创联生物制药）

Report date: 2025/08/07 16:38:43

Base Information

Drug NameDextromethorphan Hydrobromide/Quinidine Sulfate (Beijing Kangchuanglian Biopharma)
Drug Alias Name氢溴酸右美沙芬硫酸奎尼丁口崩片（2.2类改良型新药）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsCytochrome P450 2D6 inhibitorsSigma opioid receptor agonists
TargetsGlutamate [NMDA] receptorCytochrome P450 2D6Sigma opioid receptor
Therapy Area/IndicationsParalysis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Kangchuanglian Biopharmaceutical Technology Research Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Kangchuanglian Biopharmaceutical Technology Research Co Ltd
Inactive CompaniesN/A
Active IndicationsParalysis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A